On May 12, 2025, Catheter Precision, Inc. (traded as VTAK on NYSE/American), a medical device company headquartered in Fort Mill, South Carolina, announced it has secured $1.5 million through a private investment. Catheter Precision focuses on creating innovative products for the cardiac electrophysiology market, which involves the diagnosis and treatment of heart rhythm disorders such as atrial fibrillation and ventricular tachycardia. The newly raised funds are expected to accelerate the development and commercialization of the company's advanced medical devices, potentially enhancing treatment options for patients with complex cardiac arrhythmias. The announcement underscores ongoing investor interest in the medical technology sector, particularly in companies addressing critical needs in cardiovascular health. Catheter Precision’s leadership expressed optimism that the investment will enable further research and expansion of their product portfolio. The company’s activities align with broader trends in healthcare innovation, where private funding plays a key role in bringing new medical technologies to market.